Scios And Medtronic To Develop Heart Failure Treatment

. has announced its entry into a research collaboration with Medtronic, Inc. to study the effects of Scios’ investigational agent Natrecor (nesiritide) in combination with Medtronic’s heart failure devices and implantable infusion systems.

“We are excited to establish this collaboration as both Scios and Medtronic have a shared commitment to the diagnosis and management of heart failure in all of its manifestations,” said Scios Chief Scientific Officer George F. Schreiner, M.D., Ph.D. “This research effort between the two companies explores the potential for new heart failure treatments combining Natrecor’s unique therapeutic properties with Medtronic’s approach to the treatment of heart failure.”

In the first of a planned program of pilot clinical studies, the hemodynamic and clinical effects of Natrecor, including the effects on spontaneous activity and controlled exercise tolerance, will be evaluated using information collected by Medtronic’s Chronicle Implantable Hemodynamic Monitor (IHM) both during and after infusions of Natrecor.

The pilot feasibility study is expected to begin this quarter at the Karolinska Hospital in Stockholm.

Both Natrecor and the Chronicle IHM are currently under clinical investigation in the United States.

Natrecor is currently being reviewed by the U.S. FDA as a potential treatment for acute CHF. If approved for marketing by the FDA, Natrecor would be the first new treatment available for acute CHF in over a decade.

The Chronicle system is being studied in a worldwide multicenter clinical trial.

Medtronic expects to file for U.S. and European marketing approvals for this system by the end of this year.

Scios is a biopharmaceutical company developing novel treatments for cardiovascular and inflammatory diseases.

The company’s disease-based technology platform integrates expertise in protein biology with combinatorial and medicinal chemistry to identify novel targets and rationally design large and small-molecule compounds to treat cardiovascular and inflammatory diseases, two of the world’s leading unmet medical needs.

Shopping Dragon Pharma LLC Online

Oxymetholon

Synthetic Anabolic Steroidal Agent
Prime Substance: Oxymetholone
Branded by: Dragon Pharma Labs
Amount: 1 X 100 pastilles (50 mg/tab)

Cut Mix 150

Injectable Anabolic Steroid
Basal Ingredient: Testosterone Propionate, Drostanolone Propionate, Trenbolone Acetate
Manufacturer: Dragon Pharmaceuticals
Amount: 1 X 10 ml (150 mg/ml)

Trenbolone 200 - Discount Price

Administration: Injection
Main Constituent: Trenbolone Enanthate
Branded by: Dragon Pharma Labs
Package: 30 x 10 mL vial (200 mg/mL)
Price: 30 x $57.00

Oxymetholon - Discount Price

Administration: Oral
Base Constituent: Oxymetholone
Produced by: Dragon Pharma Labs
Pack: 30 x 100 pastilles (50 mg/tablet)
Price: 30 x $51.00

Clenbuterol - Cheap Price

Administration: Oral
Principal Constituent: Clenbuterol Hydrochloride
Branded by: Dragon Pharma LLC
Package: 20 x 100 pills (40 mcg/pastille)
Price: 20 x $25

Parabolan 100 - Bulk Price

Administration: Injection
Main Component: Trenbolone Hexahydrobenzylcarbonate
Branded by: Dragon Pharma
Package: 10 x 10 mL vial (100 mg/mL)
Price: 10 x $69.00

Anavar

Synthetic Anabolic Steroidal Agent
Principal Substance: Oxandrolone
Branded by: Dragon Pharmaceutical
Amount: 1 X 100 tablets (50 mg/tab)

Trenbolone 200 [10 Vials]

Injectable Steroid for Muscle Growth
Active Chemical Name: Trenbolone Enanthate
Made by: Dragon Pharma Labs
10 Vials [10 mL per Vial (200 mg/ml)]
Price: 10 x $77.00 = $770.00 in Total

EQ 300 [10 Vials]

Injectable Steroid for Muscle Growth
Principal Ingredient: Boldenone Undecylenate
Manufacturer: Dragon Pharma Labs
10 Vials [10 mL per Vial (300 mg/ml)]
Price: 10 x $42.00 = $420.00 in Total

Parabolan 100 [10 Vials]

Injectable Steroid for Muscle Growth
Active Chemical Name: Trenbolone Hexahydrobenzylcarbonate
Branded by: Dragon Pharma
10 Vials [10 mL per Vial (100 mg/ml)]
Price: 10 x $69.00 = $690.00 in Total

Enanthat 400

Injectable Steroid for Muscle Growth
Main Constituent: Testosterone Enanthate
Produced by: Dragon Pharma
10 mL Sterile Multi-dose Vial (400 mg/mL)

Dianabol

Oral Steroid for Muscle Growth
Active Ingredient: Methandrostenolone
Produced by: Dragon Pharma LLC
100 pills (20 mg/tab)